Theophylline Tablet, Extended Release
Product Images NDC 70095-017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 70095-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Theophylline-300mg-lbl (Spl Pdp 300mg)

Theophylline-300mg-lbl (Spl Pdp 300mg)
Description not available.*
FDA Label Image

Theophylline-450mg-lbl (Spl Pdp 450mg)

Theophylline-450mg-lbl (Spl Pdp 450mg)
Each uncoated extended-release tablet contains Theophylline USP 450 mg, manufactured by Harman Finochem Limited. The usual dosage and storage information are provided on the package insert, and the tablets are distributed by Sun Pharmaceutical Industries. This product is an Finished Dosage Form (FDF) for extended-release of Theophylline. For more information, refer to the provided manufacturing and distribution details.*
FDA Label Image

Spl-structure (Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.